Value202020212022202320242025TTMSelling/general/admin expenses18.03 M24.52 M42.39 M58.09 M199.47 M191.33 M159.35 MResearch & development57 M84.25 M130.22 M168.53 M240.16 M332.06 M332.06 MOperating income-74.95 M-107.7 M-167.88 M-222.61 M-338.85 M516.77 M-249.44 MNon-Operating Income, Total1.14 M61 K4.97 M13.28 M40.92 M51.63 M51.63 MInterest expense, net of interest capitalized———————Non-Operating Income, excl. Interest Expenses1.14 M61 K4.97 M13.28 M40.92 M51.27 M51.68 MUnusual income/expense—————357 K—Pretax income-73.81 M-107.64 M-163.92 M-214.53 M-298.41 M465.14 M863.85 MEquity in earnings—————0—Taxes00000180 K—Non-controlling/minority interest———————After tax other income/expense17 K1 00000———Net income before discontinued operations-73.81 M-107.64 M-163.92 M-214.53 M-298.41 M465.32 M-219.69 MDiscontinued operations———————Net income-73.81 M-107.64 M-163.92 M-214.53 M-298.41 M465.32 M-219.69 MDilution adjustment———————Preferred dividends———————Diluted net income available to common stockholders73.81 M107.64 M163.92 M214.53 M298.41 M465.32 M465.32 MBasic earnings per share (Basic EPS)——-3.15-3.69-3.69-4.95-4.96Diluted earnings per share (Diluted EPS)——-3.15-3.69-3.69-4.95-4.96Average basic shares outstanding——51.98 M58.07 M80.78 M94.06 M374.31 MDiluted shares outstanding——51.98 M58.07 M80.78 M94.06 M374.31 MEBITDA—————-101.24 M—EBIT—————-105.14 M—Cost of revenue—————1.08 M—Other cost of goods sold———————Depreciation & amortization (cash flow)673 K478 K966 K-5.17 M-12.13 M3.9 M-15.43 M
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.